Boston Scientific : Position on FDA Update About Use of Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease

On July 11, 2023, the U.S. Food and Drug Administration published a letter to healthcare providers stating that, based on its review of the totality of the available data and analyses,...

Related Keywords

Boston ,Massachusetts ,United States ,Washington ,Germany ,Michaelr Jaff ,Marianne Brodmann ,Blake Rouhani ,Las Vegas ,Lauren Tengler ,Drug Administration ,Boston Scientific ,Twitter ,Facebook ,Peripheral Interventions ,Drug Eluting Vascular Stent System ,Drug Coated Balloon ,Trial Long Term Outcomes ,Germany Jun ,Year Overall Results ,Ravish Sachar ,Long Lesion Substudy ,Femoropopliteal Artery Disease ,Drug Eluting Stent Versus Bare Metal Stents ,Primary Results ,Year Efficacy ,Safety Results ,Eluvia Polymer Coated Drug Eluting Stent ,Cardiovasc Intervent ,